Dendreon Files for Chapter 11 Bankruptcy Protection - Bloomberg
11/10/14
![]()
Dendreon Files for Chapter 11 Bankruptcy Protection
Bloomberg
Dendreon Corp. (DNDN), the maker of prostate-cancer drug Provenge, filed for Chapter 11 bankruptcy protection, potentially wiping out shareholders in a company that pioneered the use of patients' immune systems to fight tumors. The agreement calls for ...
Dendreon to Pursue Sale or Reorganization in BankruptcyWall Street Journal
Biotech Dendreon files for Chapter 11 to restructure massive debtsThe Seattle Times
Dendreon files Chapter 11, plans to restructureAtlanta Business Chronicle
Puget Sound Business Journal (Seattle) (blog)
all 166 news articles »
[more]
Bloomberg
Dendreon Corp. (DNDN), the maker of prostate-cancer drug Provenge, filed for Chapter 11 bankruptcy protection, potentially wiping out shareholders in a company that pioneered the use of patients' immune systems to fight tumors. The agreement calls for ...
Dendreon to Pursue Sale or Reorganization in BankruptcyWall Street Journal
Biotech Dendreon files for Chapter 11 to restructure massive debtsThe Seattle Times
Dendreon files Chapter 11, plans to restructureAtlanta Business Chronicle
Puget Sound Business Journal (Seattle) (blog)
all 166 news articles »
- Feeds Categories: